Biomarkers /
CCNB2
Overview
Cyclin B2 (CCNB2) is a gene that encodes a member of the cyclin family that functions as a regulator of cyclin-dependent kinases (CDKs). Cyclin B2 is involved in the regulation of the cell cycle and associates with the Golgi region. Missense mutations, nonsense mutations, silent mutations, nonstop extensions, and frameshift insertions are observed in cancers such as bone cancer, endometrial cancer, and skin cancer.
Clinical Trials
Significance of CCNB2 in Diseases
References
1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta
2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.
3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.
4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.